Unlocking the value of human biosamples
ACL Lorem QUANT E102 - 34
For Patients
For Healthcare
Providers
For Researchers
For Biobanks & Biorepositories
About us
We are a biospecimen facilitator and vendor with added value services, via affiliations with biorepositories and biobanks worldwide. Metabio’s SaaS system can increase revenue & sample value for biobanks and biorepositories, while addressing current and future needs of patients and the industry.
Value Delivered
1
Data-mining
Data-mining - Researchers can locate specimens with specific profiles from a broad spectrum of data (clinical, environmental, disorder-progression, analyses) in real-time among separate biobanking entities, without compromising patient rights or IP issues. Metabio provides data cohort information, including total sample availability across numerous associated biobanks. The ease and speed with which data and samples can be located increases their value to the researcher and biobank equally.
2
Harmonization -
Lack of industry protocol and language standards has lead to a broad range of terminology and abbreviations. Metabio’s searchable database harmonizes the data received from every source to HL7 or openEHR standard - essentially fixing one of the major challenges faced by researchers, and increasing the efficiency and sales for biobanks.
2
e-consent
Upon entry to a clinical facility, patients may enroll in our e-consent program. They can then monitor and manage their consent-status at any time, and all of the involved entities are immediately informed of any change. These changes are immediately reflected in the access-rights of associated samples, thus streamlining the response to any regulatory or legislative developments. We believe this is key to onboarding both patients and aligning with future trends in personalized medicine and patient-privacy. By giving patients complete control over the use of their physical data we ensure the ownership and usage-scenarios for this most precious resource.
4
Longitudinal synchronization
This is accomplished without changing any part of the internal systems that hospitals or biobanks use. The longitudinal tracking of data does not require significant effort in resources, capital, or mode of work from the entities involved - Metabio’s system tracks, records, and manages the data as it is produced.
Metabio’s platform integrates data from four distinct sources:
- Pre-acquisition data from healthcare facilities (EMRs, EHRs),
- Patient health status data
- Research data assigned to biospecimen cohorts and
- Biospecimen management and analyses data from biobanks.
>